Literature DB >> 10777703

Mechanism of regulation of HGF/SF gene expression in fibroblasts by TGF-beta1.

P Harrison1, L Bradley, A Bomford.   

Abstract

The effect of transforming growth factor beta 1 (TGF-beta1) on levels of hepatocyte growth factor/scatter factor (HGF/SF) gene transcripts was investigated in the human lung embryonic fibroblast cell line, MRC-5. TGF-beta1 markedly reduced the expression of the 6. 0-kb and 3.0-kb HGF/SF mRNA, which encode full-length HGF/SF, but it had little effect on the expression of the alternatively spliced 1. 5-kb mRNA, which encodes NK2, a competitive HGF/SF antagonist. Using actinomycin D to block RNA synthesis, it was observed that TGF-beta1 had little effect on the stability of the 1.5-kb NK2 mRNA but increased the rate of degradation of the 6.0- and 3.0-kb HGF/SF mRNA transcripts by a mechanism that was dependent on new protein synthesis. TGF-beta1 minimally increased rather than reduced HGF/SF promoter activity in cells transiently transfected with chloramphenicol acetyltransferase (CAT) reporter genes driven by HGF/SF gene 5'-flanking sequences. In MRC-5 cells, TGF-beta1 modulates HGF/SF gene transcripts at the posttranscriptional level in order to favour expression of the 1.5-kb mRNA that encodes the truncated protein NK2. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10777703     DOI: 10.1006/bbrc.2000.2612

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Hepatocyte growth factor mediates angiopoietin-induced smooth muscle cell recruitment.

Authors:  Hanako Kobayashi; Laura M DeBusk; Yael O Babichev; Daniel J Dumont; Pengnian Charles Lin
Journal:  Blood       Date:  2006-04-25       Impact factor: 22.113

2.  Biological roles of hepatocyte growth factor-Met signaling from genetically modified animals.

Authors:  Takashi Kato
Journal:  Biomed Rep       Date:  2017-10-18

Review 3.  Hepatocyte growth factor in lung repair and pulmonary fibrosis.

Authors:  Ronald Allan M Panganiban; Regina M Day
Journal:  Acta Pharmacol Sin       Date:  2010-12-06       Impact factor: 6.150

4.  Tpl2 regulates intestinal myofibroblast HGF release to suppress colitis-associated tumorigenesis.

Authors:  Vasiliki Koliaraki; Manolis Roulis; George Kollias
Journal:  J Clin Invest       Date:  2012-10-15       Impact factor: 14.808

Review 5.  Preclinical and clinical evaluation of MET functions in cancer cells and in the tumor stroma.

Authors:  V Finisguerra; H Prenen; M Mazzone
Journal:  Oncogene       Date:  2016-03-21       Impact factor: 9.867

6.  Transforming growth factor-β1 selectively inhibits hepatocyte growth factor expression via a micro-RNA-199-dependent posttranscriptional mechanism.

Authors:  Ognoon Mungunsukh; Regina M Day
Journal:  Mol Biol Cell       Date:  2013-05-08       Impact factor: 4.138

7.  Hepatocyte Growth Factor Mediates Enhanced Wound Healing Responses and Resistance to Transforming Growth Factor-β₁-Driven Myofibroblast Differentiation in Oral Mucosal Fibroblasts.

Authors:  Jordanna Dally; Jabur S Khan; Alex Voisey; Chrisandrea Charalambous; Hannah L John; Emma L Woods; Robert Steadman; Ryan Moseley; Adam C Midgley
Journal:  Int J Mol Sci       Date:  2017-08-24       Impact factor: 5.923

Review 8.  Hepatocyte Growth Factor Isoforms in Tissue Repair, Cancer, and Fibrotic Remodeling.

Authors:  Ognoon Mungunsukh; Elizabeth A McCart; Regina M Day
Journal:  Biomedicines       Date:  2014-11-05

9.  Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression.

Authors:  Erika L Spaeth; Jennifer L Dembinski; A Kate Sasser; Keri Watson; Ann Klopp; Brett Hall; Michael Andreeff; Frank Marini
Journal:  PLoS One       Date:  2009-04-07       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.